Status:
COMPLETED
Comparison of Serum SIRT-1 and MMP-9 Levels of Patients With Bronchiectasis and Healthy Controls
Lead Sponsor:
Cumhuriyet University
Conditions:
Bronchiectasis Adult
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this a cross-sectinol study is to measure the levels of MMP-9 and SIRT-1 levels in patients with bronchiectasis and healthy controls. The aim is to compare the serum levels of these mol...
Detailed Description
In the overall study population of 60 subjects who applied to the Sivas Cumhuriyet University Faculty of Medicine Research and Practice Hospital Chest Diseases Clinic. The study population was selecte...
Eligibility Criteria
Inclusion
- Bronchiectasis patients who were symptoms (cough, sputum production)
- Individuals whose diagnosis was confirmed by a high-resolution chest CT scan taken within the previous year
Exclusion
- Individuals with bronchiectasis associated with cystic fibrosis and who had a worsening episode
- individuals who were pregnant or nursing
- those with low comprehension
- taken antibiotics during the previous four weeks
Key Trial Info
Start Date :
November 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 2 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06589492
Start Date
November 2 2020
End Date
September 2 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cumhuriyet University
Sivas, Si̇vas Centre, Turkey (Türkiye)